The scatterplots showed that, as the expression of COL17A1/GBP4/CDC6 increased and the risk score increased, the survival time of each pancreatic cancer patient decreased and the proportion of death increased (Figure 2A). The gene discussed is GBP4; the disease is familial pancreatic carcinoma.